NCT04672655Completed
Overcoming Barriers and Obstacles to Adopting Diabetes Devices (ONBOARD) Trial
Source: ClinicalTrials.gov · Last updated 5 Sept 2025
Brief summary (registry, in English)
This study is a comprehensive, multicomponent behavioral intervention package (ONBOARD; OvercomiNg Barriers \& Obstacles to Adopting Diabetes Devices). ONBOARD will provide adults with T1D the skills to maximize benefit and minimize daily interference from barriers associated with Continuous Glucose Monitoring (CGM) and increase readiness for closed loop.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 150 (actual)
- First submitted
- 11 Dec 2020
- Start date
- 17 Feb 2021
- Primary completion date
- 16 Sept 2024
- Lead sponsor
- Molly Tanenbaum
- Diseases
- Type 1 diabetes
- NCT number
- NCT04672655
What you commit to
- Study type: Interventional
- Participants enrolled: 150
- From 17 Feb 2021 to the primary completion date, 16 Sept 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Subject has a medical disorder that in the judgment of the investigator will interfere with completion of any aspect of the protocol.
- Subject has a neurologic disorder that in the judgment of the investigator will affect completion of the protocol.
Who the study is looking for
- Subject is age 18-50 years at time of enrollment
- Subject must not have been using CGM regularly for past 6 months
- Subject has a clinical diagnosis of type 1 diabetes
- Subject comprehends spoken and written English
Age in the registry: 18 years to 50 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Stanford University Coordinator of this site? Confirm its status | Stanford | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.